About Teva

Investor Relations

Teva Worldwide

press Releases - 1999

Teva Pharmaceutical Industries Ltd. to Launch Generic Equivalent of Cardizem CD in All Dosage Forms Immediately
petach Tikva, Israel, December 27, 1999.

Teva Pharmaceutical Industries Ltd. Signs Letter of Intent to Acquire Novopharm Limited
petach Tikva, Israel, December 2, 1999.

Teva Pharmaceutical Receives First FDA Approval of Buproprion Tablets
Jerusalem, Israel, November 30, 1999

Teva Pharmaceutical Industries Ltd. Responds to Israeli News Articles
Jerusalem, Israel, November 15, 1999

Teva Pharmaceutical Industries Ltd. and H. Lundbeck A/s Form Strategic Alliance for the Co-Development and European Marketing Rights of Two Parkinson's Disease Drugs
Jerusalem, Israel, November 9, 1999

Teva Pharmaceutical Industries Ltd. Reports 1999 Third Quarter and Nine Months Financial Results 1999 Third Quarter Net Income Up 43%, In-market Sales of Copaxone - Increase 68% Vs. Third Quarter 1998 declares Regular Quarterly Cash Dividend
Jerusalem, Israel, November 1, 1999

Teva Pharmaceutical Industries Confirms Discussions to Acquire Novopharm Ltd.
Jerusalem, Israel, October 19, 1999

Teva Pharmaceutical Industries Ltd. and Bio-technology General Corp. Announce Strategic Alliance in the Development and Worldwide Commercialization of Generic Biotechnology Products
Jerusalem, Israel, September 30, 1999

Teva Pharmaceutical Industries Limited Announces Completion of Tender Offer for Copley Pharmaceutical, Inc.
Jerusalem, Israel, September 14, 1999

Teva Pharmaceutical Industries Ltd. to Acquire Copley Pharmaceutical, Inc.
Jerusalem, Israel and Canton, Ma, August 10, 1999

Teva Pharmaceutical Industries Ltd. Announces 1999 Second Quarter and Six Month Financial Results; Net Income Up 82%, Sales of Copaxone Increase 92% Vs. 1998 Second Quarter
Jerusalem, Israel, July 29, 1999

Teva's Settlement for Class Actions Approved By Israeli Court
Jerusalem, Israel, May 18, 1999

Teva Pharmaceutical Industries Ltd. Receives Approval From the Swiss Intercantonal Medicines Control Office (IKS) for Sale of Copaxone® in Switzerland
Jerusalem, Israel, May 11, 1999

Teva Pharmaceutical Industries Limited Condensed Consolidated Statements of Income (in Thousands, Except Earnings Per ADR)
may 3, 1999

Teva Pharmaceutical Industries Ltd. Announces First Quarter 1999 Results
Jerusalem, Israel, May 6, 1999

Teva Enters into Settlement Agreement
Jerusalem, Israel, March 25, 1999

Teva Pharmaceutical Industries Ltd. Reports 1998 Year End and Fourth Quarter Financial Results
Jerusalem, Israel, February 22, 1999

Archive: 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999